Fenugreek trials reported lower blood glucose, but reporting problems limit interpretation
A meta-analysis found improvements in several laboratory measures, with no clear effect on its insulin-resistance measure.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reported lower fasting and after-meal blood glucose with fenugreek, alongside lower HbA1c and insulin values. The insulin-resistance measure did not show a statistically significant effect. These findings concern laboratory outcomes. Because the abstract omits key trial details and contains inconsistent numerical reporting, it offers limited support for judging clinical usefulness.
The abstract's insulin-resistance point estimate falls outside its stated confidence interval. Participant characteristics, control treatments and trial durations are also missing, preventing a reliable assessment of whom the findings apply to.
Outcomes did not agree
Glucose, HbA1c, insulin and insulin resistance were analyzed as separate outcomes. Favorable findings for several measures do not settle the uncertain insulin-resistance result, and the abstract does not report effects on symptoms or complications.
Why the reporting matters
The authors combined controlled trials and explored differences between studies. However, inconsistent reporting makes some estimates difficult to interpret from the abstract alone; checking the underlying data would be necessary before relying on those numbers.
The original publication
The effects of fenugreek (Trigonella foenum-graecum) seed on glycemic parameters: An updated systematic review and meta-analysis of randomized controlled trials.
Chehregosha F, Fakhr L, Tarighat-Esfanjani A et al.
Avicenna J Phytomed · 2025
- PubMed ID
- 41509111
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.